What is Orthofix Medical Inc. (OFIX)?

Orthofix Medical Inc. (OFIX) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of OFIX?

The current price of OFIX is $10.04. Prices are updated in real time on Stocks360.

What is OFIX's price-to-earnings (PE) ratio?

OFIX's trailing twelve-month PE ratio is -6.54, based on current price and earnings per share data available on Stocks360.

What is OFIX's market capitalization?

OFIX's market capitalization is $405,833,386.00, placing it in the small-cap tier.

Orthofix Medical Inc. (OFIX)

Stock analysis · NASDAQ · Healthcare · Medical - Devices

$10.04

Market Cap

$405.83M

PE (TTM)

-6.54

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.62

Day Range

$9.68 – $10.15

52-wk Range

$8.50 – $16.99

Avg Volume

N/A

Volume

294.98K

Orthofix Medical Inc. (OFIX) is a publicly traded company in the Healthcare sector. Latest price: $10.04. Market cap $405.83M. Trailing PE -6.54. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-29 · $15.32 2026-10-28 · $10.04 (-34.46%)

Earnings

Most Recent

Aug 5, 2026

EPS $-0.39 vs est. $-0.41

Beat by $0.02

Next Earnings

Nov 9, 2026

EPS estimate $0.11

Proprietary Signals

Signal snapshot temporarily unavailable.

About Orthofix Medical Inc.

Orthofix Medical Inc., founded in 1980 and headquartered in Lewisville, Texas, operates as a global medical technology company focusing on devices and biologics. Its reach extends across the United States, several European nations including Italy, Germany, France, and the United Kingdom, as well as Brazil and other international markets. The company's operations are divided into two main segments: Global Spine and Global Orthopedics. Within the Global Spine division, Orthofix is responsible for the development, production, and distribution of bone growth stimulators. These devices are designed to facilitate bone fusion and serve as a therapeutic intervention for fractures located outside the spine and in the limbs. This segment also creates and commercializes a range of motion preservation and fixation implant products utilized in spinal surgical procedures. Furthermore, it supplies physicians with various tissue forms and synthetic-based regenerative biologic solutions to address a wide spectrum of spinal and orthopedic conditions. The Global Orthopedics segment concentrates on the design, development, and commercialization of specialized orthopedic products. These offerings are…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-6.54×
P/S (TTM)	0.49×
P/B	0.96×
P/FCF (TTM)	-15.01×
EV / EBITDA	5.86×
EV / Sales	0.64×
Earnings Yield	-15.03%
Free Cash Flow Yield	-6.66%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$536.64M
Revenue (TTM)	$833.19M
Net Income (TTM)	-$60.99M
Free Cash Flow (TTM)	-$15.47M
Net Debt	$130.81M
Working Capital	$289.12M
Gross Margin	69.59%
Operating Margin	-3.05%
Net Margin	-7.41%
Return on Equity	-14.05%
Return on Invested Capital	-3.55%